160
Participants
Start Date
May 31, 2008
Primary Completion Date
May 31, 2009
Study Completion Date
September 30, 2009
epoetin beta
Subcutaneous administration of epoetin beta 36,000 IU once-weekly for 12 weeks
placebo
Subcutaneous administration of placebo once-weekly for 12 weeks
Chugoku/Shikoku Region, Chugoku/Shikoku
Chubu Region, Chūbu
Hokkaido/Tohoku Region, Hokkaido/Tohoku
Kanto/Koshinetsu Region, Kanto/Koshinetsu
Kinki/Hokuriku Region, Kinki/Hokuriku
Kyushu Region, Kyushu
Lead Sponsor
Chugai Pharmaceutical
INDUSTRY